Oncology Sales General And Administrative To Revenue from 2010 to 2025

TOIIW Stock  USD 0.02  0  25.00%   
Oncology Institute Sales General And Administrative To Revenue yearly trend continues to be fairly stable with very little volatility. Sales General And Administrative To Revenue will likely drop to 0 in 2025. During the period from 2010 to 2025, Oncology Institute Sales General And Administrative To Revenue regression line of quarterly data had mean square error of  0.00000001 and geometric mean of  0. View All Fundamentals
 
Sales General And Administrative To Revenue  
First Reported
2010-12-31
Previous Quarter
0.001484
Current Value
0.001319
Quarterly Volatility
0.00008967
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Oncology Institute financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncology Institute's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.8 M, Interest Expense of 8.2 M or Selling General Administrative of 67.6 M, as well as many indicators such as Price To Sales Ratio of 0.51, Dividend Yield of 0.0235 or PTB Ratio of 2.88. Oncology financial statements analysis is a perfect complement when working with Oncology Institute Valuation or Volatility modules.
  
Check out the analysis of Oncology Institute Correlation against competitors.
For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Oncology Stock Analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.